Table 4.

Bioavailability (F, considering first-pass) and fraction absorbed (fa, without first pass) reported in the literature.

Parameter	Aprepitant	Celecoxib	Itraconazole	Nimodipine	Ritonavir
Bioavailability (F)	0.59	0.39	0.16	0.035	0.75
	[27]	[29]	[32,33]	[25,26]	[8]
Fraction absorbed (fa)	0.59	0.39	0.16	0.35	0.75
	[27]	[29]	[32,33]	[25,26]	[8]